312 related articles for article (PubMed ID: 17236209)
1. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
Frutos S; Rodriguez-Mias RA; Madurga S; Collinet B; Reboud-Ravaux M; Ludevid D; Giralt E
Biopolymers; 2007; 88(2):164-73. PubMed ID: 17236209
[TBL] [Abstract][Full Text] [Related]
2. An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface.
Bannwarth L; Reboud-Ravaux M
Biochem Soc Trans; 2007 Jun; 35(Pt 3):551-4. PubMed ID: 17511649
[TBL] [Abstract][Full Text] [Related]
3. Dimer disruption and monomer sequestration by alkyl tripeptides are successful strategies for inhibiting wild-type and multidrug-resistant mutated HIV-1 proteases.
Bannwarth L; Rose T; Dufau L; Vanderesse R; Dumond J; Jamart-Grégoire B; Pannecouque C; De Clercq E; Reboud-Ravaux M
Biochemistry; 2009 Jan; 48(2):379-87. PubMed ID: 19105629
[TBL] [Abstract][Full Text] [Related]
4. Development of low molecular weight HIV-1 protease dimerization inhibitors.
Hwang YS; Chmielewski J
J Med Chem; 2005 Mar; 48(6):2239-42. PubMed ID: 15771466
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization.
Bouras A; Boggetto N; Benatalah Z; de Rosny E; Sicsic S; Reboud-Ravaux M
J Med Chem; 1999 Mar; 42(6):957-62. PubMed ID: 10090778
[TBL] [Abstract][Full Text] [Related]
6. Dimerization inhibitors of HIV-1 protease.
Boggetto N; Reboud-Ravaux M
Biol Chem; 2002 Sep; 383(9):1321-4. PubMed ID: 12437124
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of HIV-1 protease by interface peptides.
Schramm HJ; Billich A; Jaeger E; Rücknagel KP; Arnold G; Schramm W
Biochem Biophys Res Commun; 1993 Jul; 194(2):595-600. PubMed ID: 8343146
[TBL] [Abstract][Full Text] [Related]
8. Computational proteomics analysis of binding mechanisms and molecular signatures of the HIV-1 protease drugs.
Verkhivker G
Artif Intell Med; 2009; 45(2-3):197-206. PubMed ID: 18926674
[TBL] [Abstract][Full Text] [Related]
9. Novel strategies for targeting the dimerization interface of HIV protease with cross-linked interfacial peptides.
Bowman MJ; Chmielewski J
Biopolymers; 2002; 66(2):126-33. PubMed ID: 12325162
[TBL] [Abstract][Full Text] [Related]
10. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
Louis JM; Clore GM; Gronenborn AM
Nat Struct Biol; 1999 Sep; 6(9):868-75. PubMed ID: 10467100
[TBL] [Abstract][Full Text] [Related]
11. The folding and dimerization of HIV-1 protease: evidence for a stable monomer from simulations.
Levy Y; Caflisch A; Onuchic JN; Wolynes PG
J Mol Biol; 2004 Jun; 340(1):67-79. PubMed ID: 15184023
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations of HIV-1 protease monomer: Assembly of N-terminus and C-terminus into beta-sheet in water solution.
Yan MC; Sha Y; Wang J; Xiong XQ; Ren JH; Cheng MS
Proteins; 2008 Feb; 70(3):731-8. PubMed ID: 17729281
[TBL] [Abstract][Full Text] [Related]
13. A folding inhibitor of the HIV-1 protease.
Broglia RA; Provasi D; Vasile F; Ottolina G; Longhi R; Tiana G
Proteins; 2006 Mar; 62(4):928-33. PubMed ID: 16385559
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies on inhibitors of HIV protease: a target for drug design.
Jayaraman S; Shah K
In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
[TBL] [Abstract][Full Text] [Related]
15. Yeast two-hybrid assay for examining human immunodeficiency virus protease heterodimer formation with dominant-negative inhibitors and multidrug-resistant variants.
Todd S; Laboissière MC; Craik CS
Anal Biochem; 2000 Jan; 277(2):247-53. PubMed ID: 10625514
[TBL] [Abstract][Full Text] [Related]
16. Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model.
Wang W; Kollman PA
J Mol Biol; 2000 Nov; 303(4):567-82. PubMed ID: 11054292
[TBL] [Abstract][Full Text] [Related]
17. Triterpenes as potential dimerization inhibitors of HIV-1 protease.
Quéré L; Wenger T; Schramm HJ
Biochem Biophys Res Commun; 1996 Oct; 227(2):484-8. PubMed ID: 8967903
[TBL] [Abstract][Full Text] [Related]
18. Rapid synthesis and in situ screening of potent HIV-1 protease dimerization inhibitors.
Lee SG; Chmielewski J
Chem Biol; 2006 Apr; 13(4):421-6. PubMed ID: 16632254
[TBL] [Abstract][Full Text] [Related]
19. New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer.
Merabet N; Dumond J; Collinet B; Van Baelinghem L; Boggetto N; Ongeri S; Ressad F; Reboud-Ravaux M; Sicsic S
J Med Chem; 2004 Dec; 47(25):6392-400. PubMed ID: 15566308
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
Louis JM; Dyda F; Nashed NT; Kimmel AR; Davies DR
Biochemistry; 1998 Feb; 37(8):2105-10. PubMed ID: 9485357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
